Information on the conclusion of the Amgros commissioning agreement for the medicinal product Vitrakvi (larotrectinib) Text automatically translated in your browsing language Automatically translated

This prior notification is an indication of Amgros’ expected conclusion of the contract for the placing in service of the medicinal product in section 3.1. Amgros will enter into commissioning agreements with all interested parties, and Amgros therefore invites anyone who potentially wants to enter into Amgros' commissioning agreements for the medicines below to express interest by sending relevant information including price to kontakt@amgros.dk. Amgros expects to offer the covered medicinal product as a framework contract on public tender at a later date, and it is expected that the tender will be published within the next 12 months, but this will depend on several factors. Even when the tender is published, Amgros will continue to conclude commissioning agreements on standard terms with interested parties, but it will not be possible to negotiate terms, including the price of the commissioning agreement, from then on. The final terms of the tenders will be set out in the tender documents when they are published. In relation to section 11.2, it should be noted that the contract notice for the medicinal product covered will be published when the call for tenders is published, and that the date in section 11.2 is for guidance only. Text automatically translated in your browsing language Automatically translated

33600000 - Pharmaceutical products